2023-509688-25-00招募中1 期
Phase IB Study to Assess the Safety, Tolerability and Efficacy of PM14 in combination with Atezolizumab in Pretreated Patients with Selected Advanced Solid Tumors
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 50
- 试验地点
- 5
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Clinical Development Oncology Unit
Scientific
Pharma Mar S.A.
研究点 (5)
Loading locations...
相似试验
已完成
1 期
A phase Ib study to investigate the safety and effect of BR-0032024-516338-37-00SentryX B.V.6
招募中
1 期
A Phase IB Study to determine efficacy and safety of Durvalumab and/or novel anti-cancer agents, with or without chemotherapy, in patients with previously untreated NSCLC2024-511956-42-00AstraZeneca AB44
已完成
1 期
Assessing the safety and tolerability of oral ruxolitinib in combination with 5-azacitidine in patients with advanced phase myeloproliferative neoplasms (MPN), including myelodysplastic syndromes (MDS) or acute myeloid leukaemia (AML) arising from MPN.Myeloproliferative neoplasms (MPN), including myelodysplastic syndromes (MDS) or acute myeloid leukaemia (AML) arising from MPNMalignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissueCancerISRCTN16783472The University of Birmingham (UK)58
进行中（未招募）
不适用
Phase I study evaluating tolerability, safety, pharmacokinetics, and efficacy of combined ONO-4059 and R-MPV therapy for PCNSLjRCT2071230124Ono Pharmaceutical Co.,LTD20
招募中
1 期
Evaluate the Safety, Tolerability, Biodistribution Characteristics and Preliminary Efficacy of BioTTT001Meningeal MetastasisNCT07264569Henan Cancer Hospital42